Condition: Solid Tumor, Adult · Sponsor: University of Oklahoma
The purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.
This description comes directly from the study's public registry record.
Ingrid Block · 1-405-271-8777 · SCC-IIT-Office@ouhsc.edu
Lead Gynecology Oncology Nurse · 1-405-271-8777 · SCC-IIT-Office@ouhsc.edu
Always discuss trial participation with your own doctor first.
| Stephenson Cancer Center | Oklahoma City, Oklahoma, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04928508